NeuroMedix Poised to Realize Next Stage of Business Plan through Strategic Alliance or Acquisition
After very successful pre-clinical trials for its lead product ‘Minozac,’ Neuromedix is planning further work on this promising Alzheimer’s treatment. - December 01, 2006
Press Releases 1 - 1 of 1